top of page


PharmaLogic agrees to acquire Lantheus radiopharmaceutical CDMO business and New Jersey manufacturing facility
PharmaLogic has signed a definitive agreement to acquire Lantheus' radiopharmaceutical CDMO operations and Springfield manufacturing facility, expanding specialist production capabilities for therapeutic radiopharmaceuticals.

nuaxia
4 days ago2 min read


BDR Pharma agrees to acquire controlling stake in Acme's oral formulations business
BDR Pharma has agreed to acquire a controlling interest in Acme's oral solid formulations business from shareholders led by PAG, strengthening its capabilities in specialist formulations while leaving Acme's sterile injectables operation outside the transaction.

nuaxia
Nov 102 min read


AGC Biologics expands dual-site pharmaceutical manufacturing contract to more than €500 million
AGC Biologics has expanded a long-term manufacturing agreement with an unnamed global pharmaceutical company to more than €500 million, adding six commercial biologics programmes at its Copenhagen facility.

nuaxia
Nov 42 min read


Zydus completes acquisition of Sterling Biotech fermentation-based API business
Zydus Lifesciences has completed its acquisition of Sterling Biotech's fermentation-based active pharmaceutical ingredients business, expanding its manufacturing capabilities in India.

nuaxia
Nov 32 min read


FDA approves NRx preservative-free ketamine injection amid US hospital supply shortage
The FDA has approved NRx Pharmaceuticals' preservative-free generic ketamine injection, adding a US-manufactured supply option during an ongoing shortage of injectable ketamine.

nuaxia
Nov 22 min read


ALK expands Catalent manufacturing partnership with DKK 500m investment in allergy tablet capacity
ALK is investing approximately DKK 500 million to expand its long-term manufacturing partnership with Catalent and increase capacity for fast-dissolving allergy immunotherapy tablets.

nuaxia
Oct 12 min read


Sanofi and Cheplapharm agree transfer of 20 mature medicines and three manufacturing sites
Sanofi and Cheplapharm have agreed a major mature-medicines transaction covering 20 products and three manufacturing sites in France, Hungary and Singapore.

nuaxia
Sep 162 min read


CordenPharma invests €80m to expand sterile injectable capacity to 500m units annually
CordenPharma is investing €80 million to expand aseptic fill-finish operations at its Caponago site in Italy, increasing projected sterile injectable capacity to up to 500 million units annually.

nuaxia
Sep 112 min read


ADCAN Pharma and Pinnacle Life Science agree licensing and technology-transfer deal for 12 oncology products
ADCAN Pharma and Pinnacle Life Science have entered into a licensing and technology-transfer partnership covering 12 oncology products and their planned local manufacture in the UAE.

nuaxia
Sep 31 min read


BeOne Medicines reaches US government agreement on cancer medicine access and pricing
BeOne Medicines has reached a voluntary agreement with the US government covering cancer medicine access, future pricing and continued investment in US pharmaceutical manufacturing.

nuaxia
Sep 22 min read


Bristol Myers Squibb ends $380 million Cellares CAR-T manufacturing partnership
BMS concluded that Cellares’ automated Cell Shuttle platform could not meet the specific requirements for commercial Breyanzi production, prompting Cellares to cut around 100 positions.

nuaxia
Aug 273 min read


4basebio and Genezen expand collaboration to advance synthetic DNA for viral vector manufacturing
The commercial partnership combines 4basebio’s cell-free hpDNA platform with Genezen’s viral vector CDMO capabilities to provide cell and gene therapy developers with an alternative to conventional plasmid DNA manufacturing.

nuaxia
Aug 273 min read


Project Farma acquires SimoTech to expand GMP automation and digital manufacturing capabilities
The acquisition adds SimoTech’s automation engineering and digital manufacturing expertise to Project Farma’s existing life sciences manufacturing services, creating a broader offering spanning facility strategy through GMP operations.

nuaxia
Aug 122 min read


Wise Equity agrees to acquire E-Pharma Trento to expand Italian pharmaceutical CDMO platform
The proposed acquisition gives Wise Equity control of a specialist oral solid-dose manufacturer with established capabilities in effervescent, soluble, orally disintegrating and sublingual formulations.

nuaxia
Aug 102 min read
bottom of page